| Hans-Günter Meyer-Thompson | Hepatitiden
Optimization of direct anti-viral agent treatment schedule: Focus on HCV genotype 3.
Optimization of direct anti-viral agent treatment schedule: Focus on HCV genotype 3.
Morisco F, Granata R, Camera S, Ippolito A, Milella M, Conti F, Masetti C, Smedile A, Tundo P, Santantonio T, Valvano MR, Termite A, Gatti P, Messina V, Iacobellis A, Librandi M, Caporaso N, Andriulli A; ITAL-C consortium.
United European Gastroenterol J. 2018 Mar;6(2):225-237. doi: 10.1177/2050640617717158.